Teva Pharmaceutical Industries (TEVA) EPS (Basic) Growth (1y) (2010 - 2026)
Powered by 
Analysis
Teva Pharmaceutical Industries (TEVA) EPS (Basic) Growth (1y) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.61 Bn | 38.95 Bn | 2.15 Bn | -301.82% |
| 2 | Viatris | 19.18 Bn | 18.30 Bn | 1.46 Bn | -2,504.14% |
| 3 | Dr Reddys Laboratories | 9.85 Bn | 9.68 Bn | 396.53 Mn | -71.71% |
| 4 | Amneal Pharmaceuticals | 5.48 Bn | 5.35 Bn | 334.51 Mn | 92.15% |
| 5 | Bausch Health Companies | 2.36 Bn | 518.87 Mn | 2.10 Bn | 100.90% |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | - |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 184.35% |
| 8 | Amphastar Pharmaceuticals | 994.21 Mn | 704.09 Mn | 93.47 Mn | 5.21% |
| 9 | Fennec Pharmaceuticals | 405.56 Mn | 364.31 Mn | 17.15 Mn | 150.13% |
| 10 | RedHill Biopharma | 176.59 Mn | 176.59 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -301.82% |
| Mar 31, 2026 | 65.56% |
| Dec 31, 2025 | 268.82% |
| Sep 30, 2025 | 208.58% |
| Jun 30, 2025 | 131.69% |
| Mar 31, 2025 | -58.17% |
| Dec 31, 2024 | -158.39% |
| Sep 30, 2024 | -611.63% |
| Jun 30, 2024 | 4.53% |
| Mar 31, 2024 | 303.68% |
| Dec 31, 2023 | 134.65% |
| Sep 30, 2023 | 17.69% |
| Jun 30, 2023 | -223.35% |
| Mar 31, 2023 | 74.18% |
| Dec 31, 2022 | -777.08% |
| Sep 30, 2022 | -79.24% |
| Jun 30, 2022 | -231.55% |
| Mar 31, 2022 | -1,278.01% |
| Dec 31, 2021 | -200.03% |
| Sep 30, 2021 | 106.99% |